Z Orthop Unfall 2023; 161(06): 678-682
DOI: 10.1055/a-1754-0051
Case Report

Therapy of a Chronically Infected Total Femur Prothesis in a 40-year-old Patient

Article in several languages: deutsch | English
1   Klinik und Poliklinik für Unfallchirurgie, Universitätsklinikum Regensburg, Regensburg, Deutschland (Ringgold ID: RIN39070)
,
Florian Baumann
1   Klinik und Poliklinik für Unfallchirurgie, Universitätsklinikum Regensburg, Regensburg, Deutschland (Ringgold ID: RIN39070)
,
Volker Alt
1   Klinik und Poliklinik für Unfallchirurgie, Universitätsklinikum Regensburg, Regensburg, Deutschland (Ringgold ID: RIN39070)
› Author Affiliations

Abstract

We report a case of a patient who was treated in 1999 at the age of 19 years with a proximal femur replacement due to Ewing sarcoma. After several infection-associated exchange procedures, the patient presented with a fistula and chronic infection of a total femur prosthesis in August 2019 at the age of 40 years. Interdisciplinary treatment with a 3-stage exchange procedure and implantation of a silver-coated total femur prosthesis was successfully performed and hip disarticulation could be avoided. After a follow-up of 2 years, the patient showed uneventful wound healing and full weight bearing without crutches.



Publication History

Received: 20 November 2021

Accepted after revision: 27 January 2022

Article published online:
04 April 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Anagnostakos K, Wilmes P, Schmitt E. et al. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop 2009; 80: 193-197
  • 2 Khalilpour P, Lampe K, Wagener M. et al. Ag/SiO(x)C(y) plasma polymer coating for antimicrobial protection of fracture fixation devices. J Biomed Mater Res B Appl Biomater 2010; 94: 196-202
  • 3 Walter N, Rupp M, Baertl S. et al. Periprosthetic joint infection : patients benefit from a multidisciplinary team approach. Bone Joint Res 2022; 11: 8-9
  • 4 Fiore M, Sambri A, Zucchini R. et al. Silver-coated megaprosthesis in prevention and treatment of peri-prosthetic infections: a systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery. Eur J Orthop Surg Traumatol 2021; 31: 201-220
  • 5 Alt V, Heiss C, Rupp M. Treatment of a Recurrent Periprosthetic Joint Infection with an Intramedullary Knee Arthrodesis System with Low-Amount Metallic Silver Coating. J Bone Jt Infect 2019; 4: 111-114
  • 6 Ismat A, Alt V, Heiss C. et al. Limb-saving Knee Arthrodesis with a Silver-coated Arthrodesis Rod in a Patient with Aspergillus Osteomyelitis of the Knee. Strategies Trauma Limb Reconstr 2020; 15: 121-125
  • 7 Hardes J, von Eiff C, Streitbuerger A. et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol 2010; 101: 389-395
  • 8 Glehr M, Leithner A, Friesenbichler J. et al. Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J 2013; 95-B: 988-992